Regulus Therapeutics Inc 's

• RGLS's Stock Performance relative to its Competitors

Vtv Therapeutics Inc Share Performance -6.97% 30 Days

Vtv Therapeutics Inc Profile Vtv Therapeutics Inc operates as a biotechnology company focused on the discovery and development of medicines for the treatment of various diseases. They employ a research-oriented business model, leveraging their expertise in drug discovery and development to identify potential therapeutic targets and advance them through preclinical and clinical stages. Their ultimate goal is to bring innovative and effective treatments to patients, improving their quality of life. More about Vtv Therapeutics Inc 's Market Share

Ptc Therapeutics inc Share Performance -5.54% 30 Days

Ptc Therapeutics inc Profile PTC Therapeutics Inc's business model revolves around the research, development, and commercialization of innovative treatments for rare and genetic diseases. More about Ptc Therapeutics inc 's Market Share

Prothena Corporation Public Limited Company Share Performance +1.93% Over The Past 5 Days

Prothena Corporation Public Limited Company Profile Prothena Corporation is a biotechnology company that focuses on developing novel therapies for diseases related to protein misfolding and amyloidosis. Their business model includes leveraging their expertise in antibody and protein engineering to develop and commercialize drug candidates, collaborating with pharmaceutical partners to advance their therapeutic programs, and continuously conducting research and development to expand their pipeline of potential treatments. Their goal is to address unmet medical needs and provide innovative solutions for patients suffering from devastating diseases. More about Prothena Corporation Public Limited Company's Market Share

Pharming Group N v Share Performance -0.26% Over The Past 5 Days

Pharming Group N v Profile Pharming Group N.V. operates on a business model focused on the development, production, and commercialization of innovative therapeutic products for the treatment of rare diseases and unmet medical needs. The company primarily generates revenue by selling its approved products in various geographic markets and through strategic collaborations with pharmaceutical partners. Pharming Group N.V. also engages in research and development activities to expand its product pipeline and explore potential new treatments. More about Pharming Group N v 's Market Share

Morphic Holding inc Share Performance +1.28% 30 Days

Morphic Holding inc Profile Morphic Holding Inc's business model revolves around the development and commercialization of novel integrin therapeutics. They utilize a platform that combines structural biology, medicinal chemistry, and computational biology to design and develop small-molecule drugs. By strategically targeting and inhibiting integrin receptors, Morphic aims to address various diseases while offering potential benefits to patients. More about Morphic Holding inc 's Market Share

Sources: Regulus Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Tuesday, September 8, 2026 4:49 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Regulus Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.